Jacques Turgeon, BPharm, PhD, chief scientific officer of Tabula Rasa HealthCare (TRHC) and Veronique Michaud, BPharm, MSc, PhD, chief operation officer of TRHC Precision Pharmacotherapy Research & Development Institute, authored “Medication Monitor: Decreasing Adverse Drug Events” in the January/February issue of Today’s Geriatric Medicine Magazine. Read the full article.
Moorestown, NJ, January 13, 2020 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today a client retention rate of 99.1% in the PACE (Programs of All-inclusive Care for the Elderly) market to begin 2020. PACE organizations nationwide rely on TRHC’s PACE division, CareVention HealthCare,™ for technology, services, and consulting to optimize outcomes and maintain regulatory compliance. CareVention’s lead offering for PACE providers is medication... Read More
Moorestown, NJ, December 16, 2019 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, continues its market penetration in PACE (Programs of All-inclusive Care for the Elderly). Spurred by TRHC’s CareVention HealthCare™ division, TRHC is providing more than 80% of PACE providers with at least one TRHC PACE solution. TRHC will continue to expand in January 2020, with five new PACE agreements. In addition to these new... Read More
Tabula Rasa HealthCare Co-Founder and President Orsula V. Knowlton, PharmD, MBA, was featured in the Managed Healthcare Executive article, “Eight Trends Expected to Shape Managed Care Pharmacy in 2020.” The piece highlights the trends that experts expect will shape the pharmacy industry next year, including Knowlton’s perspective on pharmacists emerging as primary care providers.
Moorestown, NJ, December 11, 2019 – Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC) Senior Director of Learning and Development Lauren E. Steffen, PharmD, BCGP presented at the Institute for Health Improvement’s National Forum on Quality Improvement in Health Care held December 9-11, 2019 in Orlando, FL. TRHC is a healthcare technology company advancing the field of medication safety. The Company is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to... Read More
Moorestown, NJ, December 5, 2019 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces a partnership with Hudson Headwaters Health Network, a Queensbury, NY-based nonprofit that operates 19 health centers in northern New York state. Beginning in January 2020, Hudson Headwaters pharmacists will license the MedWise™ technology to identify patients at high risk for medication-related problems and complete Medication Safety Reviews. “TRHC’s partnership with Hudson... Read More
In a recent edition of Healthcare IT News, Tabula Rasa Healthcare was featured in an article outlining how LIFE St. Mary uses TRHC’s pharmacy platform, to improve patient outcomes. Read the full article.
Steve Gilbert, MBA, RPh, BCPS, BCBG, CPHQ, Vice President, Performance Improvement, Tabula Rasa HealthCare was featured in the article “How to Train Staff on New Tech: Tips for Pharmacy Managers” in the November 19 issue of Drug Topics. Access the PDF of Drug Topics.
In this episode, Jenny Bingham, PharmD, BCACP, discusses telepharmacy services. Dr. Jenny Bingham, is a Clinical Pharmacy Specialist at SinfoniaRx. Throughout her career, she has launched several novel programs aimed to improve the quality of care for patients in a variety of settings. She manages a transition of care program that has led to: reduced readmission rates at 30-, 60-, and 90-days post-discharge; decreased Medicare beneficiary expenditures; and a substantial return-on-investment. Dr. Bingham is committed... Read More
Executive Summary In the United States, over-the-counter (OTC) products are consumed by millions of people to self-medicate and, thereby, take an active role in their health care. However, despite public belief, not all OTCs are safe for all people. Over-the-counter products containing drugs with strong anticholinergic properties, such as chlorpheniramine and diphenhydramine, are ubiquitous and can cause myriad side effects, particularly for older Americans. Some anticholinergic side effects can be temporarily severe and disabling. But,... Read More